High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19

Abstract

High-flow therapy is a useful treatment in ARDS in order to avoid intubation or as a bridge therapy, and no increased mortality was observed secondary to the delay in intubation. After initiating HFNC, a ROX index below 4.94 predicts the need for intubation.